Ananda Ghosh
Stock Analyst at HC Wainwright & Co.
(2.83)
# 1,972
Out of 5,008 analysts
9
Total ratings
77.78%
Success rate
16.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ananda Ghosh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SKYE Skye Bioscience | Initiates: Buy | $20 | $1.66 | +1,104.82% | 1 | Sep 30, 2025 | |
| PEPG PepGen | Maintains: Buy | $8 → $12 | $4.91 | +144.40% | 1 | Sep 25, 2025 | |
| MAZE Maze Therapeutics | Reiterates: Buy | $50 | $27.86 | +79.47% | 3 | Sep 18, 2025 | |
| RNA Avidity Biosciences | Maintains: Buy | $68 → $87 | $46.95 | +85.30% | 1 | Sep 12, 2025 | |
| IVA Inventiva | Assumes: Buy | $20 | $5.52 | +262.32% | 1 | Sep 3, 2025 | |
| ANNX Annexon | Reiterates: Buy | $14 | $3.07 | +356.03% | 1 | Aug 15, 2025 | |
| GPCR Structure Therapeutics | Maintains: Buy | $75 → $60 | $28.42 | +111.12% | 1 | Aug 7, 2025 |
Skye Bioscience
Sep 30, 2025
Initiates: Buy
Price Target: $20
Current: $1.66
Upside: +1,104.82%
PepGen
Sep 25, 2025
Maintains: Buy
Price Target: $8 → $12
Current: $4.91
Upside: +144.40%
Maze Therapeutics
Sep 18, 2025
Reiterates: Buy
Price Target: $50
Current: $27.86
Upside: +79.47%
Avidity Biosciences
Sep 12, 2025
Maintains: Buy
Price Target: $68 → $87
Current: $46.95
Upside: +85.30%
Inventiva
Sep 3, 2025
Assumes: Buy
Price Target: $20
Current: $5.52
Upside: +262.32%
Annexon
Aug 15, 2025
Reiterates: Buy
Price Target: $14
Current: $3.07
Upside: +356.03%
Structure Therapeutics
Aug 7, 2025
Maintains: Buy
Price Target: $75 → $60
Current: $28.42
Upside: +111.12%